Literature DB >> 1456579

CD3+ and CD4+ cells adoptively transfer experimental hypersensitivity pneumonitis.

M Schuyler1, K Gott, G Shopp, L Crooks.   

Abstract

To characterize the cells responsible for transfer of adoptive murine experimental hypersensitivity pneumonitis (EHP), we depleted Micropolyspora faeni (M. faeni)-sensitized C3H/HeJ spleen cell (SC) cultures of CD3+, CD4+, or CD8+ cells before administration to recipients. We determined the length of time sensitization persists, the ability of cultured lung-associated lymph node (LALN) cells to transfer EHP, and the ability of cultured SC from animals subjected to two, four, or eight weekly intratracheal challenges of M. faeni to transfer EHP. The extent of pulmonary inflammatory response after challenge with intratracheal M. faeni was used to determine adoptive transfer. Depletion reduced the proportion of CD3+ cells from 21 to 1%, CD4+ cells from 15 to 3%, and CD8+ cells from 7 to 1% in the cultured SC population. The proportion of B cells exhibited reciprocal changes. Cultured SC could transfer EHP. Depletion of CD3+ and CD4+, but not CD8+ cells, ablated or diminished the capacity to transfer EHP. Sensitized cells persisted in recipients for at least 8 wk. Cultured LALN cells could transfer EHP. Recipients of cultured SC from 4- and 8-wk donors exhibited less extensive pulmonary abnormalities than recipients of cultured SC from 2-wk donors. The proportion of CD3+, CD4+, CD8+, B cells, and macrophages was the same in cultured cells from 2-, 4-, and 8-wk donors. We conclude that the active cells in SC cultures are CD3+, CD4+, and CD8- T cells, and there are differences in the ability of cultured cells to adoptively transfer EHP that are dependent on the nature of the donor but not on the phenotype of the cell population.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1456579     DOI: 10.1164/ajrccm/146.6.1582

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  10 in total

1.  Adoptive transfer of allergen-specific CD4+ T cells induces airway inflammation and hyperresponsiveness in brown-Norway rats.

Authors:  A Haczku; P Macary; T J Huang; H Tsukagoshi; P J Barnes; A B Kay; D M Kemeny; K F Chung; R Moqbel
Journal:  Immunology       Date:  1997-06       Impact factor: 7.397

2.  Experimental hypersensitivity pneumonitis: influence of Th2 bias.

Authors:  M Schuyler; K Gott; V Mapel; A Cherne; K J Nikula
Journal:  Int J Exp Pathol       Date:  1999-12       Impact factor: 1.925

3.  The role of MIP-1alpha in experimental hypersensitivity pneumonitis.

Authors:  M Schuyler; K Gott; V French
Journal:  Lung       Date:  2004       Impact factor: 2.584

4.  Extrinsic allergic alveolitis: comparative study of the bronchoalveolar lavage profiles and radiological presentation.

Authors:  M Sterclova; M Vasakova; J Dutka; J Kalanin
Journal:  Postgrad Med J       Date:  2006-09       Impact factor: 2.401

Review 5.  Hypersensitivity pneumonitis.

Authors:  H B Kaltreider
Journal:  West J Med       Date:  1993-11

6.  Is IL12 necessary in experimental hypersensitivity pneumonitis?

Authors:  Mark Schuyler; Katherine Gott; Amy Cherne
Journal:  Int J Exp Pathol       Date:  2002-04       Impact factor: 1.925

7.  Transfer of allergic airway responses with antigen-primed CD4+ but not CD8+ T cells in brown Norway rats.

Authors:  A Watanabe; H Mishima; P M Renzi; L J Xu; Q Hamid; J G Martin
Journal:  J Clin Invest       Date:  1995-09       Impact factor: 14.808

8.  Experimental hypersensitivity pneumonitis: role of MCP-1.

Authors:  Mark Schuyler; Katherine Gott; Amy Cherne
Journal:  J Lab Clin Med       Date:  2003-09

9.  Co-modulation of T cells and B cells enhances the inhibition of inflammation in experimental hypersensitivity pneumonitis.

Authors:  Olivier Courtemanche; Carole-Ann Huppé; Pascale Blais Lecours; Ophélie Lerdu; Joanny Roy; Jean-François Lauzon-Joset; Marie-Renée Blanchet; Mathieu C Morissette; David Marsolais
Journal:  Respir Res       Date:  2022-10-08

Review 10.  The regulation of pulmonary immunity.

Authors:  M F Lipscomb; D E Bice; C R Lyons; M R Schuyler; D Wilkes
Journal:  Adv Immunol       Date:  1995       Impact factor: 3.543

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.